Viking Therapeutics Inc [NASDAQ: VKTX] closed the trading session at $3790000.0 on 2025-06-25. The day’s price range saw the stock hit a low of $25.78, while the highest price level was $27.38.
The stocks have a year to date performance of -48.63 percent and weekly performance of 2.50 percent. The stock has been moved at -34.71 percent over the last six months. The stock has performed 0.41 percent around the most recent 30 days and changed -3.18 percent over the most recent 3-months.
If compared to the average trading volume of 3.79M shares, VKTX reached to a volume of 4164341 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about Viking Therapeutics Inc [VKTX]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for VKTX shares is $90.26 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on VKTX stock is a recommendation set at 1.21. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Cantor Fitzgerald have made an estimate for Viking Therapeutics Inc shares, keeping their opinion on the stock as Overweight, with their previous recommendation back on April 29, 2025. While these analysts kept the previous recommendation, Goldman raised their target price to Neutral. The new note on the price target was released on April 08, 2025, representing the official price target for Viking Therapeutics Inc stock. Previously, the target price had yet another raise to $102, while Scotiabank analysts kept a Sector Outperform rating on VKTX stock.
The Price to Book ratio for the last quarter was 3.59, with the Price to Cash per share for the same quarter was set at 7.58.
VKTX stock trade performance evaluation
Viking Therapeutics Inc [VKTX] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 2.50. With this latest performance, VKTX shares gained by 0.41% in over the last four-week period, additionally sinking by -34.71% over the last 6 months – not to mention a drop of -32.68% in the past year of trading.
Viking Therapeutics Inc [VKTX]: An insightful look at the core fundamentals
Return on Equity for this stock declined to -13.98%, with Return on Assets sitting at -13.98%.
Viking Therapeutics Inc [VKTX]: Institutional Ownership
There are presently around $70.04%, or 71.56% of VKTX stock, in the hands of institutional investors. The top three institutional holders of VKTX stocks are: FMR LLC with ownership of 16.54 million shares, which is approximately 14.9835%. VANGUARD GROUP INC, holding 10.1 million shares of the stock with an approximate value of $$535.26 million in VKTX stocks shares; and VANGUARD GROUP INC, currently with $$319.45 million in VKTX stock with ownership which is approximately 5.4589%.
